Supernus Pharmaceuticals, Inc. Common Stock (NASDAQ: SUPN) last traded at $45.85, down 3.37% on the session. The quote above updates while this page is open; the figures below are drawn from Supernus Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Supernus Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker SUPN. Its market capitalisation is $2.67 billion.
Valuation measures for Supernus Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.67B |
|---|---|
| Enterprise value | $2.88B |
| Price / sales | 3.21 |
| Price / book | 2.58 |
| Beta | 0.44 |
Trailing-twelve-month figures tagged in Supernus Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $830.44M |
|---|---|
| Net income (TTM) | -$109.89M |
| EPS (TTM) | -$1.92 |
| Operating margin | -15.71% |
| Return on equity | -10.66% |
| Cash | $179.95M |
Range and volume for SUPN over the past 52 weeks.
| 52-week high | $59.68 |
|---|---|
| 52-week low | $42.45 |
| Volume | 724.8K |
| Average volume | 858.8K |
| Previous close | $47.45 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.